Toth Financial Advisory Corp Has $3.89 Million Position in iShares Biotechnology ETF $IBB

Toth Financial Advisory Corp boosted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 24.3% during the third quarter, HoldingsChannel.com reports. The firm owned 26,927 shares of the financial services provider’s stock after acquiring an additional 5,272 shares during the period. Toth Financial Advisory Corp’s holdings in iShares Biotechnology ETF were worth $3,887,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Citigroup Inc. boosted its stake in shares of iShares Biotechnology ETF by 27.0% during the 2nd quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock valued at $515,398,000 after buying an additional 865,823 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of iShares Biotechnology ETF by 74.2% during the second quarter. JPMorgan Chase & Co. now owns 833,196 shares of the financial services provider’s stock worth $105,408,000 after acquiring an additional 355,000 shares in the last quarter. Employees Retirement System of Texas acquired a new stake in iShares Biotechnology ETF during the second quarter valued at $25,049,000. Millennium Management LLC grew its stake in iShares Biotechnology ETF by 140.8% in the first quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock valued at $5,330,000 after purchasing an additional 143,893 shares in the last quarter. Finally, Jones Financial Companies Lllp increased its position in iShares Biotechnology ETF by 763.3% in the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock worth $19,347,000 after purchasing an additional 133,744 shares during the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 2.4%

Shares of iShares Biotechnology ETF stock opened at $170.20 on Friday. The stock has a 50-day simple moving average of $163.31 and a 200-day simple moving average of $145.18. iShares Biotechnology ETF has a 52-week low of $107.43 and a 52-week high of $174.40.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were given a $0.1831 dividend. This is a positive change from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, December 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.